PoroUS

About:

PoroUS combines 3D ultrasound technology and image guidance with sophisticated spectral signal processing to ensure osteoporosis diagnoses.

Website: https://nlc.health/venture/porous/

Top Investors: European Innovation Council, NLC

Description:

PoroUS combines non-ionizing 3D ultrasound technology and image guidance with sophisticated spectral signal processing to ensure the osteoporosis diagnosis. PoroUS’ cortical ultrasound back-scatter analysis offers a novel way to detect microstructural changes (porosity and thickness) in the cortical bone. PoroUS provides a precision- and operating independence-tool, which will improve the cost effectiveness and reduce the economic burden by preventing fragility fractures.

Total Funding Amount:

2.5M EUR

Headquarters Location:

Amsterdam, Noord-Holland, The Netherlands

Founded Date:

2019-01-01

Contact Email:

info(AT)nlc.health

Founders:

Number of Employees:

251-500

Last Funding Date:

2022-06-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai